Sign in to view content

Particulate Matter From Syringes Used for Intravitreal Injections

Roger A. Goldberg, MD, MBA

Video
Published 2020

Related

An Analysis of Particle Contamination and Protein Aggregation From Syringes Used for Intravitreal Injection
Jason Noble, MD, FRCSC
On Demand Cases, Courses, and Papers
2021
Inhibition of Complement C3 in GA with NGM621: Phase 1 Study Results
David A. Eichenbaum, MD, FASRS
Updates from the Field
2021
Noninferiority of 1.7% Povidone–Iodine for Endophthalmitis Prophylaxis After Intravitreal Injections Compared With 5% Povidone–Iodine in an Office Setting
Kamal Kishore, MD, MBBS
Annual Meeting Talks
2022

Category: Instrumentation and Devices

See more